Sex Health: FDA Approves Self-Collection Wand for Cervical Cancer Screening

For decades, cervical cancer screening has looked basically the same: a doctor's office, sitrrups, a cold speculum, and a test many people quietly dread, even when they know how important it is. Now, for the first time, that experience is getting a long-overdue update.

Earlier this month, the FDA approved the Teal Wand, the first and only at-home vaginal self-collection device for cervical cancer screening in the U.S. It's a big deal, not just for convenience, but for access, comfort, and the future of sexual and reproductive health.

Cervical cancer is one of the most preventable cancers out there. Regular screening can catch precancerous changes long before they turn into cancer at all. And yet, more than 1 in 4 women in the U.S. are behind on screening.

The reasons are familiar: lack of time, lack of access, transportation issues, difficulty getting appointments - and yes, discomfort with speculum exams. Even when Pap smears aren't painful, they're invasive, outdated, and enough to make many people put screening off.

Health experts have been searching for ways to close the gap. At-home testing may be one of the most promising solutions yet.

Cervical cancer screening has evolved a lot over the last few decades as research clarified what actually causes the disease. There are currently two main screening methods: Pap tests (cytology), which looks at cervical cells under a microscope to see if they've become abnormal or precancerous, and HPV tests, which look for high-risk strains of human papillomavirus, especially types like HPV 16 and 18, which cause about 90% of cervical cancers.

Today, medical guidelines increasingly recommend HPV primary screening because it's more sensitive at identifying risk earlier. The Teal Wand uses the same highly-accurate HPV test doctors use in clinics. The only difference is how the sample is collected.

Until recently, even HPV testing required a speculum exam and clinician-collected samples. Last year, the FDA approved a self-collection option that could be done in a healthcare setting, but not at home. The Teal Wand changes that.

It's designed for one-handed, at-home use and doesn't require reaching the cervix directly. Instead, it collects cells from high in the vagina, which research shows is sufficient for accurate HPV testing. Here's how it works:

Insert the wand until you feel slight resistance. Extend the sponge tip and turn the dial. Withdraw the wand and detach the sponge tip. Drop it into the sample collection and mail to a certified lab. Receive results, with support from Teal's telehealth medical team. That's it. No speculum or stirrups.

This approval isn't just about comfort (though comfort matters!). It's also about autonomy, equity, and meeting people where they are. At-home screening opens the doors for people who can't take time off work, don't have reliable transportation, live far from OB/Gyn providers, or have trauma, anxiety, or physical discomfort tied to speculum exams.

With FDA approval, insurance coverage becomes possible, and access expands even further.

Sexual health doesn't exist in a vacuum. Feeling empowered, informed, and comfortable in your body directly affects whether you seek care at all.

The Teal Wand represents a real shift toward healthcare that respects people's lives, boundaries, and preferences without sacrificing accuracy or safety. It's a reminder that innovation in sexual health doesn't always mean something flashy. Sometimes, it means finally fixing something that's been uncomfortable for far too long.

Kits are expected to become available starting in June 2026, beginning in California and expanding nationwide. If this sounds like an option you've been waiting for, it may be worth keeping an eye on.